Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer

MicroRNA Sequence and Expression Analysis in Breast Tumors by Deep Sequencing

(2011) T. A. Farazi et al.   CANCER RESEARCH

MicroRNA-205 Inhibits Src-Mediated Oncogenic Pathways in Renal Cancer

(2011) S. Majid et al.   CANCER RESEARCH

MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer

(2011) Jelena Radojicic et al.   CELL CYCLE

miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion

(2011) Adam Fowler et al.   EUROPEAN JOURNAL OF CANCER

miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 Protein

(2011) Altaf A. Dar et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Transcriptional Coregulator RIP140 Represses E2F1 Activity and Discriminates Breast Cancer Subtypes

(2010) A. Docquier et al.   CLINICAL CANCER RESEARCH

MicroRNA Cluster 221-222 and Estrogen Receptor α Interactions in Breast Cancer

(2010) Gianpiero Di Leva et al.   JNCI-Journal of the National Cancer Institute

Deconstructing the molecular portraits of breast cancer

(2010) Aleix Prat et al.   Molecular Oncology

Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells

(2010) N Bhatnagar et al.   Cell Death & Disease

In situ detection of mature microRNAs by labeled extension on ultramer templates

(2009) Gerard J. Nuovo et al.   BIOTECHNIQUES

microRNA-205 Regulates HER3 in Human Breast Cancer

(2009) M. V. Iorio et al.   CANCER RESEARCH

miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase C 

(2009) P. Gandellini et al.   CANCER RESEARCH

Suppression of cell growth and invasion by miR-205 in breast cancer

(2009) Hailong Wu et al.   CELL RESEARCH

TargetingmiR-205in breast cancer

(2009) Hailong Wu et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

MicroRNAs in Cancer: Small Molecules With a Huge Impact

(2009) Marilena V. Iorio et al.   JOURNAL OF CLINICAL ONCOLOGY

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

(2008) Philip A. Gregory et al.   NATURE CELL BIOLOGY